Building risk assessments and monitoring plans that focus on what is important into trial design lays the groundwork for a successful drug program by increasing data integrity and safeguarding patients. Our risk-based quality management (RBQM) capabilities ensure that:
- Risks to critical data and processes are identified early
- Functional areas each have unique and defined monitoring strategies
- A validated, closed system (TRI OPRA) manages the process with access control and a full audit trail
- A risk log that gives the option to add integrated forward looking indicators for Central Monitoring of potential risks in near real time
Download the available brochure to learn more.